Alcami Capacity Update July 2024: Cell & Gene Therapy

Alcami is a globally recognized CDMO that partners with clients to bring life-changing medicines to patients. We deliver reliable solutions that unlock the potential of transformative medicines from discovery to commercialization through trusted partnerships with our clients, recognized industry expertise, and a proven regulatory track record. In this presentation from the July 2024 OPCU event, we provide an overview of the Analytical Development services to support end to end gene therapy. Alcami offers method development, method validation and QC testing, as well as R&D testing support, leveraging our company’s extensive expertise in various testing platforms, including separation methods, bioassays and safety testing.